** Shares of biopharma firm Cara Therapeutics CARA.O rise 14.5% to $5.61
** Cara says that its board has approved a 1-for-3 reverse stock split, effective April 15
** Cara entered into a merger agreement with privately held Tvardi Therapeutics in December
** The stock split will be under the new name Tvardi Therapeutics Inc and symbol "TVRD" after the anticipated closing of the merger
** After the closing of the merger, the combined company's total outstanding shares are expected to be about 9.4 million
** As of last close, CARA had fallen 14.2% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.